176 related articles for article (PubMed ID: 8139487)
1. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
Ghizzoni L; Bernasconi S; Virdis R; Vottero A; Ziveri M; Volta C; Iughetti L; Giovannelli G
Metabolism; 1994 Mar; 43(3):372-7. PubMed ID: 8139487
[TBL] [Abstract][Full Text] [Related]
2. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
3. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
[TBL] [Abstract][Full Text] [Related]
4. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
Sarafoglou K; Zimmerman CL; Gonzalez-Bolanos MT; Willis BA; Brundage R
J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous cortisol and growth hormone secretion interactions in patients with nonclassic 21-hydroxylase deficiency (NCCAH) and control children.
Ghizzoni L; Mastorakos G; Vottero A; Magiakou MA; Chrousos GP; Bernasconi S
J Clin Endocrinol Metab; 1996 Feb; 81(2):482-7. PubMed ID: 8636254
[TBL] [Abstract][Full Text] [Related]
6. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
Speiser PW; New MI
J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
Sarafoglou K; Himes JH; Lacey JM; Netzel BC; Singh RJ; Matern D
Horm Res Paediatr; 2011; 75(1):19-25. PubMed ID: 20798478
[TBL] [Abstract][Full Text] [Related]
8. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
Granoff AB; Chasalow FI; Blethen SL
J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
[TBL] [Abstract][Full Text] [Related]
9. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
von Schnakenburg K; Bidlingmaier F; Knorr D
Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
[TBL] [Abstract][Full Text] [Related]
10. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T; Schlaghecke R
Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
[TBL] [Abstract][Full Text] [Related]
11. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
[TBL] [Abstract][Full Text] [Related]
12. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE; Sizonenko PC
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[TBL] [Abstract][Full Text] [Related]
13. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
[TBL] [Abstract][Full Text] [Related]
14. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
Hampl R; Foretová L; Sulcová J; Stárka L
Eur J Pediatr; 1990 Jan; 149(4):232-4. PubMed ID: 2303071
[TBL] [Abstract][Full Text] [Related]
15. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
16. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
17. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
Lee PA; Urban MD; Gutai JP; Migeon CJ
Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
[TBL] [Abstract][Full Text] [Related]
18. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
19. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
20. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
Lim YJ; Yong AB; Warne GL; Montalto J
J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
